Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of RTS,S/AS01E in P. falciparum-infected and Uninfected Adults
NCT04661579Phase 2Completed
- Sponsor
- PATH
- Start
- Nov 2020
- Primary completion
- Jun 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of RTS,S in malaria (5 arms), sponsored by PATH. Primary endpoint: Time to First PCR-detectable Malaria Infection During the Active Detection of Infection (ADI) Phase in Groups 1 and 4 up to 35 weeks. Started Nov 2020; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04661579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04661579.